Terms ending in 2040
Every in-force patent on Twist Bioscience Corporation's record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,512,347 | Flexible Substrates for Nucleic Acid Synthesis In force · High confidence | Atlas Data Storage, Inc. | In force | High confidence | |
| US 11,332,738 | Barcode-Based Nucleic Acid Sequence Assembly In force · High confidence | Twist Bioscience Corporation | In force | High confidence | |
| US 11,492,728 | Variant Nucleic Acid Libraries for Antibody Optimization In force · High confidence | Twist Bioscience Corporation | In force | High confidence | |
| US 12,565,715 | Variant Nucleic Acid Libraries for Antibody Optimization In force · High confidence | Twist Bioscience Corporation | In force | High confidence | |
| US 11,492,727 | Variant Nucleic Acid Libraries for GLP1 Receptor In force · High confidence | Twist Bioscience Corporation | In force | High confidence | |
| US 12,331,427 | Antibodies That Bind GLP1R In force · High confidence | Twist Bioscience Corporation | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Twist Bioscience Corporation.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.